Duska, L. R., Java, J. J., Cohn, D. E., & Burger, R. A. (2015). Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): An NRG oncology/gynecologic oncology group study (ADS-1236)(). Gynecol Oncol.
استشهاد بنمط شيكاغوDuska, Linda R., James J. Java, David E. Cohn, و Robert A. Burger. "Risk Factors for Readmission in Patients With Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Who Are Receiving Front-line Chemotherapy On a Clinical Trial (GOG 218): An NRG Oncology/gynecologic Oncology Group Study (ADS-1236)()." Gynecol Oncol 2015.
MLA استشهادDuska, Linda R., James J. Java, David E. Cohn, و Robert A. Burger. "Risk Factors for Readmission in Patients With Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Who Are Receiving Front-line Chemotherapy On a Clinical Trial (GOG 218): An NRG Oncology/gynecologic Oncology Group Study (ADS-1236)()." Gynecol Oncol 2015.